Skip to content

Biochemical Versus Ultrasound Findings as Predictors of Fetal Loss in Cases of First Trimester Threatened Miscarriage

Biochemical Versus Ultrasound Findings as Predictors of Fetal Loss in Cases of First Trimester Threatened Miscarriage

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03797508
Enrollment
42
Registered
2019-01-09
Start date
2018-12-01
Completion date
2019-09-30
Last updated
2019-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion Threatened

Brief summary

Threatened miscarriage occurs in about one-fifth of pregnancies with an estimated miscarriage rate of 3-16% after successful demonstration of fetal cardiac activity. Various biochemical markers have been studied previously to predict the outcome of threatened miscarriage; However, the results have been conflicting. Several studies have documented that a slow embryonic heart rate at 6.0-7.0 Weeks' gestation is associated with a high rate of first trimester fetal demise. our aim: To evaluate the accuracy of ultrasound findings in comparison to serum CA125 and progesterone in predicting fetal demise in cases of first trimester threatened miscarriage. Will this pregnancy be continued after the first trimester or not?

Detailed description

we are comparing between the accuracy of vaginal ultra sound versus serum progesterone level and serum CA 125 level in predicting of fetal demise in cases of threatened miscarriage three vaginal ultrasounds will be done ) the first one will be done at six to eight weeks of pregnancy to the patients who fulfill the criteria in this us we will make sure that the cardiac pulsations are present and measure the following: 1. the fetal heart rate, 2. the crown rump length 3. gestational sac diameter 4. yolk sac diameter. b) The second ultra sound will be after two weeks from the first one to follow up the patient for pregnancy survival, take the same measures again and correlate them with the results of laboratory investigations to select the investigation which is most accurate in anticipating outcome in cases of threatened abortion. C) the third one will be at the end of first trimester (13 weeks) to ensure fetal viability. . embryonic bradycardia and absence of yolk sac or smaller yolk sac than expected for any given gestational age are prognostic factors of poor pregnancy outcome in the first 12 weeks of pregnancy women with small for age gestational sac are more prone to have miscarriage we will do laboratory investigation in the form of A) Serum progesterone: low maternal P levels have been useful in predicting spontaneous abortion in threatened pregnancies with a sensitivity of 80% (\<10 ng /mL) so, this will be our cutoff value. B) Serum CA 125 :we will take a level of 51.5 as cut off value.this is the upper level of normal we will do them once when the patient presents to us.

Interventions

DIAGNOSTIC_TESTultrasound

To evaluate the accuracy of ultrasound findings in comparison to serum CA125and progesterone in predicting fetal demise in cases of first trimester threatened miscarriage.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* Singleton Pregnancy. * Age20-35years. * Gestational age between6 to 8weeks. * Threatened miscarriage is diagnosed by vaginal bleeding, closed cervix and positive fetal life. * Patients who are sure of their dates (three regular menstrual cycles before conception without the use of hormonal contraception.

Exclusion criteria

Patients with recurrent miscarriage or pregnancy of unknown location (PUL). * Patients had ovulation induction medications or on progesterone treatment. * Patients with past medical history of diabetes mellitus or chronic hypertension. * Patients who are unsure of the last menstrual period date or with irregular menstrual cycle. * Pregnancy associated with presence of ovarian cyst. * Molar pregnancy. * Those who had a history of maternal disease which would cause an increase in CA-125level. These diseases include chronic pelvic infection, endometriosis, myoma uteri, endometrioma and lung, kidney and hepatic diseases.

Design outcomes

Primary

MeasureTime frameDescription
ultra soundthe 12th week of gestationpresence of fetal heart rate

Countries

Egypt

Contacts

Primary Contactmohamed k abdelwahab, master
m.k.ali1987@gmail.com01000849822

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026